Hsiaomei Heidi Lu
About Hsiaomei Heidi Lu
Hsiaomei Heidi Lu serves as the Vice President of Bioinformatics at Sangamo Therapeutics, Inc., a position she has held since 2022. With a strong background in bioinformatics and computational biology, she has previously worked at Ambry Genetics and Mission Bio, and holds a PhD in Biomathematics, Bioinformatics, and Computational Biology from the University of Illinois Chicago.
Current Role at Sangamo Therapeutics
Hsiaomei Heidi Lu serves as the Vice President of Bioinformatics at Sangamo Therapeutics, Inc. since 2022. In this role, she oversees bioinformatics strategies and initiatives that support the company's mission in gene therapy and genomic medicine. Her leadership is pivotal in advancing bioinformatics capabilities within the organization.
Previous Experience at Ambry Genetics
Prior to her current position, Hsiaomei Lu held multiple roles at Ambry Genetics. She served as Senior Director of Bioinformatics and Computational Biology from 2014 to 2017, and later as Vice President of Bioinformatics and Computational Biology from 2017 to 2021. Her tenure at Ambry Genetics spanned over seven years, during which she contributed to the development of bioinformatics solutions in genetic testing.
Academic Background in Bioinformatics
Hsiaomei Lu earned her Doctor of Philosophy (PhD) in Biomathematics, Bioinformatics, and Computational Biology from the University of Illinois Chicago, completing her studies from 2002 to 2009. She also studied Statistics at National Tsing Hua University for one year in 2001. Additionally, she holds a Bachelor's degree in Business Administration from National Chiao Tung University, which she completed from 1997 to 2001.
Research Experience at UC Irvine
Hsiaomei Lu worked as a Postdoctoral Researcher at the University of California, Irvine from 2010 to 2011. During this year, she engaged in research activities that contributed to her expertise in bioinformatics and computational biology, further enhancing her academic and professional qualifications.
Short Tenure at Mission Bio
In 2022, Hsiaomei Lu briefly served as Vice President of Bioinformatics at Mission Bio for eight months. This role allowed her to apply her extensive knowledge in bioinformatics within a different organizational context before transitioning to her current position at Sangamo Therapeutics.